World News: 12:19 GMT Friday 12th July 2019. [Research and Markets via Globe Newswire via SPi World News]
Dublin, July 12, 2019 (GLOBE NEWSWIRE) -- The report has been added to offering. The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.Increase in the geriatric population, growing adoption of pharmacogenomics procedure by healthcare professionals, increased awareness of patients towards personalized therapy, and the emerging prevalence of chronic diseases like cancer, tuberculosis, HIV, and others, are driving the growth of pharmacogenomics market.Based on End-user, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. The hospitals and clinics segment accounted for the largest share among end users for pharmacogenomic products, followed by research organizations and academic institutes. This is attributed to the fact that hospitals are well-equipped with molecular diagnostic lab units to cater to the different needs of the patients. Moreover, pharmacogenomics lab units at hospitals are well-equipped with highly superior systems. 1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Pharmacogenomics Market, by Technology1.4.2 Global Pharmacogenomics Market, by Application1.4.3 Global Pharmacogenomics Market, by End-user1.4.4 Global Pharmacogenomics Market, by Geography1.5 Methodology for the Research2.1 Introduction2.1.1 Overview2.1.2 Market Composition and Scenario2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market Restraints3.1.1 Global Sequencing Market by Region3.1.2 Global Polymerase Chain Reaction Market by Region3.1.3 Global Electrophoresis Market by Region3.1.4 Global Mass Spectrometry Market by Region3.1.5 Global Microarray Market by Region3.1.6 Global Others Market by Region4.1.1 Global Oncology Market by Region4.1.2 Global Psychiatry Market by Region4.1.3 Global Infectious Diseases Market by Region4.1.4 Global Neurological Diseases Market by Region4.1.5 Global Pain Management Market by Region4.1.6 Global Cardiovascular Diseases Market by Region4.1.7 Global Others Market by Region5.1.1 Global Hospitals and Clinics Market by Region5.1.2 Global Research Institutions Market by Region5.1.3 Global Academic Institutes Market by Region6.1 North America Pharmacogenomics Market6.2 Europe Pharmacogenomics Market6.3 Asia-Pacific Pharmacogenomics Market6.4 LAMEA Pharmacogenomics Market7.1 Abbott Laboratories7.2 Empire Genomics LLC7.3 Illumina, Inc.7.4 OneOme LLC7.5 Myriad Genetics Inc.7.6 Thermo Fischer Scientific, Inc.7.7 Teva Pharmaceuticals Industries Ltd.7.8 Bayer AG7.9 Opko Health, Inc. (GeneDx, Inc.)7.10 Becton, Dickinson and Company For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics
Globe Newswire: 12:19 GMT Friday 12th July 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.